Cargando…
Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation
The insulin-like growth factor-1 (IGF-1) signaling pathway is crucial for the regulation of growth and development. The correct processing of the IGF-1Ea prohormone (proIGF-1Ea) and the IGF-1 receptor (IGF-1R) peptide precursor requires proper N-glycosylation. Deficiencies of N-linked glycosylation...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873121/ https://www.ncbi.nlm.nih.gov/pubmed/35211808 http://dx.doi.org/10.1007/s00018-022-04180-x |
_version_ | 1784657395218120704 |
---|---|
author | Di Patria, Laura Annibalini, Giosuè Morrone, Amelia Ferri, Lorenzo Saltarelli, Roberta Galluzzi, Luca Diotallevi, Aurora Bocconcelli, Matteo Donati, Maria Alice Barone, Rita Guerrini, Renzo Jaeken, Jaak Stocchi, Vilberto Barbieri, Elena |
author_facet | Di Patria, Laura Annibalini, Giosuè Morrone, Amelia Ferri, Lorenzo Saltarelli, Roberta Galluzzi, Luca Diotallevi, Aurora Bocconcelli, Matteo Donati, Maria Alice Barone, Rita Guerrini, Renzo Jaeken, Jaak Stocchi, Vilberto Barbieri, Elena |
author_sort | Di Patria, Laura |
collection | PubMed |
description | The insulin-like growth factor-1 (IGF-1) signaling pathway is crucial for the regulation of growth and development. The correct processing of the IGF-1Ea prohormone (proIGF-1Ea) and the IGF-1 receptor (IGF-1R) peptide precursor requires proper N-glycosylation. Deficiencies of N-linked glycosylation lead to a clinically heterogeneous group of inherited diseases called Congenital Disorders of Glycosylation (CDG). The impact of N-glycosylation defects on IGF-1/IGF-1R signaling components is largely unknown. In this study, using dermal fibroblasts from patients with different CDG [PMM2-CDG (n = 7); ALG3-CDG (n = 2); ALG8-CDG (n = 1); GMPPB-CDG (n = 1)], we analyzed the glycosylation pattern of the proIGF-1Ea, IGF-1 secretion efficiency and IGF-1R signaling activity. ALG3-CDG, ALG8-CDG, GMPPB-CDG and some PMM2-CDG fibroblasts showed hypoglycosylation of the proIGF-1Ea and lower IGF-1 secretion when compared with control (CTR). Lower IGF-1 serum concentration was observed in ALG3-CDG, ALG8-CDG and in some patients with PMM2-CDG, supporting our in vitro data. Furthermore, reduced IGF-1R expression level was observed in ALG3-CDG, ALG8-CDG and in some PMM2-CDG fibroblasts. IGF-1-induced IGF-1R activation was lower in most PMM2-CDG fibroblasts and was associated with decreased ERK1/2 phosphorylation as compared to CTR. In general, CDG fibroblasts showed a slight upregulation of Endoplasmic Reticulum (ER) stress genes compared with CTR, uncovering mild ER stress in CDG cells. ER-stress-related gene expression negatively correlated with fibroblasts IGF-1 secretion. This study provides new evidence of a direct link between N-glycosylation defects found in CDG and the impairment of IGF-1/IGF-1R signaling components. Further studies are warranted to determine the clinical consequences of reduced systemic IGF-1 availability and local activity in patients with CDG. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04180-x. |
format | Online Article Text |
id | pubmed-8873121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-88731212022-03-02 Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation Di Patria, Laura Annibalini, Giosuè Morrone, Amelia Ferri, Lorenzo Saltarelli, Roberta Galluzzi, Luca Diotallevi, Aurora Bocconcelli, Matteo Donati, Maria Alice Barone, Rita Guerrini, Renzo Jaeken, Jaak Stocchi, Vilberto Barbieri, Elena Cell Mol Life Sci Original Article The insulin-like growth factor-1 (IGF-1) signaling pathway is crucial for the regulation of growth and development. The correct processing of the IGF-1Ea prohormone (proIGF-1Ea) and the IGF-1 receptor (IGF-1R) peptide precursor requires proper N-glycosylation. Deficiencies of N-linked glycosylation lead to a clinically heterogeneous group of inherited diseases called Congenital Disorders of Glycosylation (CDG). The impact of N-glycosylation defects on IGF-1/IGF-1R signaling components is largely unknown. In this study, using dermal fibroblasts from patients with different CDG [PMM2-CDG (n = 7); ALG3-CDG (n = 2); ALG8-CDG (n = 1); GMPPB-CDG (n = 1)], we analyzed the glycosylation pattern of the proIGF-1Ea, IGF-1 secretion efficiency and IGF-1R signaling activity. ALG3-CDG, ALG8-CDG, GMPPB-CDG and some PMM2-CDG fibroblasts showed hypoglycosylation of the proIGF-1Ea and lower IGF-1 secretion when compared with control (CTR). Lower IGF-1 serum concentration was observed in ALG3-CDG, ALG8-CDG and in some patients with PMM2-CDG, supporting our in vitro data. Furthermore, reduced IGF-1R expression level was observed in ALG3-CDG, ALG8-CDG and in some PMM2-CDG fibroblasts. IGF-1-induced IGF-1R activation was lower in most PMM2-CDG fibroblasts and was associated with decreased ERK1/2 phosphorylation as compared to CTR. In general, CDG fibroblasts showed a slight upregulation of Endoplasmic Reticulum (ER) stress genes compared with CTR, uncovering mild ER stress in CDG cells. ER-stress-related gene expression negatively correlated with fibroblasts IGF-1 secretion. This study provides new evidence of a direct link between N-glycosylation defects found in CDG and the impairment of IGF-1/IGF-1R signaling components. Further studies are warranted to determine the clinical consequences of reduced systemic IGF-1 availability and local activity in patients with CDG. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04180-x. Springer International Publishing 2022-02-24 2022 /pmc/articles/PMC8873121/ /pubmed/35211808 http://dx.doi.org/10.1007/s00018-022-04180-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Di Patria, Laura Annibalini, Giosuè Morrone, Amelia Ferri, Lorenzo Saltarelli, Roberta Galluzzi, Luca Diotallevi, Aurora Bocconcelli, Matteo Donati, Maria Alice Barone, Rita Guerrini, Renzo Jaeken, Jaak Stocchi, Vilberto Barbieri, Elena Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation |
title | Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation |
title_full | Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation |
title_fullStr | Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation |
title_full_unstemmed | Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation |
title_short | Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation |
title_sort | defective igf-1 prohormone n-glycosylation and reduced igf-1 receptor signaling activation in congenital disorders of glycosylation |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873121/ https://www.ncbi.nlm.nih.gov/pubmed/35211808 http://dx.doi.org/10.1007/s00018-022-04180-x |
work_keys_str_mv | AT dipatrialaura defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation AT annibalinigiosue defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation AT morroneamelia defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation AT ferrilorenzo defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation AT saltarelliroberta defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation AT galluzziluca defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation AT diotalleviaurora defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation AT bocconcellimatteo defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation AT donatimariaalice defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation AT baronerita defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation AT guerrinirenzo defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation AT jaekenjaak defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation AT stocchivilberto defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation AT barbierielena defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation |